Founder And Director (Intelligene Acquired By Invitae Corporation - Dec 2020)
Served a network of Oncology Academic Medical Centers (e.g. Moffitt, City Of Hope, USC Norris) and Pharma companies (e.g. Merck, Abbvie, BMS) with Computational Biology, Data Science and Product Development needs.Integrate: Gather, generate, and unify diverse sources of data - Create multiple pathways to data for a clinical-molecular repository- Establish provider networks and partners for new data- Functionalize clinical & molecular data and beyondDiscover: New value from unified data - Insights into disease progression- Virtual clinical trials through comparator groups- Empowerment of all stakeholders: patient, providers, pharma, payersTreat: Tailored clinical care decisions- Navigate clinical care pathways- Create a virtual tumor board- Match patients to clinical trialsMonitor: Longitudinal patient tracking- Inform evolving treatment- Refine care pathways- Compare treatment efficacy with real-world evidence Technology IntelliGene’s suite of proven solutions enable rapid application development:- Knowledge Base: explore integrated clinical & molecular data on thousands of patients- Data Pipeline: automated data cleaning, processing, and organization- Oncology BI: flexible data visualization and exploration- Clinical Decision Support: patient-centric analysis to empower physicians and providers